Home Search

miti - search results

If you're not happy with the results, please do another search
Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Mitesco, Inc. (MITI) is building a better model...

Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...

MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...

Mitesco (MITI) Announces Fourth Minneapolis and First Denver Lease for the Good Clinic.

Mitesco Announces Lease for Fourth Minneapolis Location and First Lease for the Good Clinic(TM) Operation in Denver MINNEAPOLIS, MN,...

Good Clinic Owned by Mitesco (MITI) In Star Tribune.

Former MinuteClinic Principals Open Walk-in Clinic in Minneapolis, Plan 3 More This Year. 50 Clinics Planned in Next Three Years.

Mitesco’s (MITI) CEO Featured In Yahoo News Video.

Michael C. Howe, CEO of Mitesco's 'Good Clinic' and Original Partner of CVS the Acquired 'Minute Clinic' on Yahoo's Finance Channel....
Good Clinic, Biotech Stock Review

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

LIVE QUOTE Nice chart ahead of its first clinic opening.. By George, they did...

Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.

Mitesco Expands Footprint for The Good Clinic to Colorado at Lennar Multi-Family Developments to Serve as Stepping Stone to National Presence
Mitesco Inc,. Biotech Stock Review

Biotech Stock Review: Mitesco (MITI) $0.03, Report Update

Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.

True Nature | Mitesco (MITI) Raising $15 Million.

LIVE CHART Mitesco, Inc. Announces up to $15 Million Unit Preferred Capital...

Institutional Analyst Newsletter. April 14, 2022.

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict LIVE QUOTE

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...